Status:
TERMINATED
F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response
Lead Sponsor:
Technische Universität Dresden
Collaborating Sponsors:
Advanced Biochemical Compounds GmbH
Conditions:
Brain Tumor
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to monitor the amino acid uptake of brain tumors, before and during radiotherapy, with positron emission tomography.
Eligibility Criteria
Inclusion
- Brain tumor
- Radiation therapy indicated
- Written consent
Exclusion
- Pregnancy
- Mental impairment
- Drug/alcohol abuse
Key Trial Info
Start Date :
December 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00180193
Start Date
December 1 2003
Last Update
August 26 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Nuclear Medicine
Dresden, Germany, 01307